COVID-19: Keeping Up With a Moving Target
May 1, 2020
May 1, 2021 (Please note that credit will no longer be issued for this activity after this date)
Registration Fee: FREE
- Physicians—2.50 AMA PRA Category 1 Credit(s)™
- Nurses— 3.2 Contact Hours
- Pharmacists — 2.50 hours – The Kentucky Board of Pharmacy has approved this program for 2.5 CE (0.25 CEU) ID number 20-15.
- Respiratory Therapists – This course has been approved by the Kentucky Board of Respiratory Care for 2.5 contact hours. Course number: 20051501
All other health care professionals completing this course will be issued a statement of participation, upon request.
Local/Regional Physicians, Residents, and other Allied Healthcare Providers
Statement of Need:
COVID-19 is a global pandemic that has already resulted in hundreds of thousands of infections and thousands of deaths, with many more anticipated.
This course will review the current data on emerging novel coronavirus and identification and management of patients exposed to coronavirus.
00:00 – Fadi Al Akhrass, MD, MBA, FACP – Introduction
02:59 – Fadi Al Akhrass, MD, MBA, FACP – COVID 19: Understanding the Science, Epidemiology, and Clinical Manifestation
16:04 – Muhannad Antoun, MD, FACP – COVID 19: Understanding the Science, Epidemiology, and Clinical Manifestation
45:26 – C. Chase Reynolds, MD – Cardiac Considerations for COVID-19
56:58 – Hayley, Trimble, MD, FACOG – COVID-19 in Relationship to OB/GYN and Pediatrics
01:04:26 – D. Bradley Akers, MD, FACP – COVID-19 and Pediatrics
01:18:17 – Michael David Cranney, DO – Tracheal intubation of COVID-19 patients
01:28:50 – Ayorinde Medaiyese, MD – Understanding the Pathophysiology and Management of ARDS
02:13:49 – Fadi Al Akhrass, MD, MBA, FACP – Treatment of COVID-19
02:20:12 – Danielle Hamilton, PharmD – Recent COVID-19 Studies
02:25:59 – Ashley Holland, PharmD – Overview of COVID-19 Studies
02:30:55 – Questions and Answers
02:42:55 – Alexis Salyers, DO – Screening Process, Leadership and Development of COVID 19 unit
02:44:55 – Tiffany Salyers, DO – Leadership, Experience and Development of Protocols
- Review epidemiology, clinical manifestations, diagnostics and management of COVID-19
- Discuss how to decrease the nosocomial spread of COVID-19 by following the proper infection prevention measures
- Review COVID-19 infection, transmission, comorbidities and clinical manifestation and laboratories tests
- Appraise how to treat and prevent thrombosis associated with COVID-19
- Appreciate the increased risk of COVID-19 in patients with cardiovascular disease
- Recognize and manage COVID-19 related cardiomyopathy
- Evaluate data on COVID-19- related pregnancy and neonatal outcomes
- Review emerging data on how pediatric patients have been affected by COVID-19
- Discuss the unintended consequences of public health interventions on pediatrics
- Discuss optimizing for successful first-attempt
- Review infection control measures to limit the transmission of COVID-19
- Recognize the effect of COVID-19 on the lungs and in the pathophysiology of ARDS
- Review current management of ARDS in COVID-19 patients and any special circumstances
- Review results of compassionate use or Remdesivir for severe COVID-19
- Analyze the Gilead trial of Remdesivir
- Review the use of Ascorbic Acid and COVID-19
- Review Hydroxychloroquine-Cohort study
- Discuss Hydroxychloroquine and Azithromycin for treatment of COVID-19
- Review the study of Lopinavir-Ritonavir in treatment of COVID-19
- Review protocols developed to address the situation of patients with suspected COVID-19
- Review strategy for patient volume and complexity
Instructions for Participation and Credit
To receive credit you are required to:
- Review video content, https://youtu.be/U_AUGk1D2yQ
- Complete the activity evaluation,
- Score 80% on the required post-test to assess the knowledge gained from reviewing the video,
- Submit the CME/CE registration and evaluation forms.
If you have questions about the participation process, please e-mail CME@pikevillehospital.org or call (606)218-3931.
Pikeville Medical Center is accredited by the Kentucky Medical Association to sponsor continuing medical education for physicians.
Pikeville Medical Center designates this “internet enduring material” for a maximum of 2.50 AMA PRA Category 1 CreditsTM. Physicians should only claim credits commensurate with the extent of their participation in the activity.
Pikeville Medical Center is approved by the Kentucky Board of Nursing as a continuing medical education provider and will award 3.2 nursing contact hours for this program.
KBN provider number 4-0042-12-20-0016 “Kentucky Board of Nursing approval of an individual nursing education provider does not constitute endorsement of program content.”
The Kentucky Board of Pharmacy has approved this program for 2.5 CE (0.25 CEU) ID number 20-15.
This course has been approved by the Kentucky Board of Respiratory Care for 2.5 contact hours. Course number: 20051501
The opinions and recommendations expressed by faculty and other experts, whose input is included in this activity, are their own and do not represent Pikeville Medical Center endorsement. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacological therapy to patients. COVID-19 is an emerging disease. New knowledge is added daily and guidance may change as the situation evolves. Please consult the CDC website regularly for the most up-to-date information.
Special Needs Statement
If you have special needs, please contact our office and we will do our best to accommodate you.